Sri Radhas Biotech India Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 14-12-2024
- Paid Up Capital ₹ 2.00 Cr
as on 14-12-2024
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2013
- Open Charges ₹ 7.33 Cr
as on 14-12-2024
- Satisfied Charges ₹ 2.77 Cr
as on 14-12-2024
About Sri Radhas Biotech India
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2013. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹7.33 Cr. The company has closed loans amounting to ₹2.77 Cr, as per Ministry of Corporate Affairs (MCA) records.
Radhakrishnan Magesh and Magesh Sheeba serve as directors at the Company.
- CIN/LLPIN
U24231TN2006PTC059414
- Company No.
059414
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Apr 2006
- Date of AGM
30 Sep 2013
- Date of Balance Sheet
31 Mar 2013
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sri Radhas Biotech India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Radhakrishnan Magesh  | Director | 03-Apr-2006 | Current |
| Magesh Sheeba | Director | 03-Apr-2006 | Current |
Financial Performance of Sri Radhas Biotech India.
Enhance accessibility to Sri Radhas Biotech India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sri Radhas Biotech India?
Unlock access to Sri Radhas Biotech India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹7.33 Cr
₹2.77 Cr
Charges Breakdown by Lending Institutions
- Others : 4.68 Cr
- Andhra Pradesh State Financial Corporation : 2.65 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Aug 2024 | Others | ₹4.68 Cr | Open |
| 19 Nov 2012 | Andhra Pradesh State Financial Corporation | ₹2.65 Cr | Open |
| 28 Mar 2022 | Hdfc Bank Limited | ₹2.77 Cr | Satisfied |
How Many Employees Work at Sri Radhas Biotech India?
Unlock and access historical data on people associated with Sri Radhas Biotech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Radhas Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Radhas Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.